In addition, previous studies have shown that Survivin is regulated by the NF-κB and PI3K/AKT signaling pathways in many cancers, such as bladder cancer, lymphoma and pancreatic cancer [11–14]. This evidence concerns the gene BIRC5 and urinary bladder cancer.